IE
ONC

Israel Englander’s BeOne Medicines Ltd ONC Stock Holding History

Israel Englander’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.56M Buy
+12,500
New +$3.68M ﹤0.01% 3318
2026
Q1 		– Sell
-20,000
Closed -$6.08M – 6539
2025
Q4 		$6.08M Sell
20,000
-30,000
-60% -$9.82M ﹤0.01% 2798
2025
Q3 		$17M Buy
+50,000
New +$15.2M 0.01% 1837
2020
Q1 		– Sell
-25,000
Closed -$4.14M – 4613
2019
Q4 		$4.14M Buy
+25,000
New +$4.15M 0.01% 2082

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Israel Englander's ONC Position: Q2 2026 in Review

Israel Englander increased its BeOne Medicines Ltd (ONC) stake by 165% in Q2 2026, buying an estimated $99.7M and bringing the position to 543,323 shares worth $155M. The position accounts for 0.06% of the portfolio, ranked #331.

Israel Englander first reported a position in ONC in Q1 2016 and has held it in 32 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Israel Englander held 543,323 shares of BeOne Medicines Ltd worth $155M as of Q2 2026.
  • Israel Englander bought 338,477 BeOne Medicines Ltd shares in Q2 2026, an estimated $99.7M.
  • BeOne Medicines Ltd made up 0.06% of Israel Englander's portfolio in Q2 2026, its #331 holding.
  • Israel Englander first reported a position in BeOne Medicines Ltd in Q1 2016 and has held it in 32 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.